1-151760181-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_031420.4(MRPL9):āc.673G>Cā(p.Val225Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000217 in 1,613,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00019 ( 0 hom., cov: 32)
Exomes š: 0.00022 ( 0 hom. )
Consequence
MRPL9
NM_031420.4 missense, splice_region
NM_031420.4 missense, splice_region
Scores
2
7
10
Splicing: ADA: 0.9997
2
Clinical Significance
Conservation
PhyloP100: 5.24
Genes affected
MRPL9 (HGNC:14277): (mitochondrial ribosomal protein L9) This is a nuclear gene encoding a protein component of the 39S subunit of the mitochondrial ribosome. Alternative splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 8. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL9 | NM_031420.4 | c.673G>C | p.Val225Leu | missense_variant, splice_region_variant | 7/7 | ENST00000368830.8 | NP_113608.1 | |
MRPL9 | NM_001300733.2 | c.571G>C | p.Val191Leu | missense_variant, splice_region_variant | 6/6 | NP_001287662.1 | ||
MRPL9 | NR_125331.2 | n.730G>C | splice_region_variant, non_coding_transcript_exon_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL9 | ENST00000368830.8 | c.673G>C | p.Val225Leu | missense_variant, splice_region_variant | 7/7 | 1 | NM_031420.4 | ENSP00000357823 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152174Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
29
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000367 AC: 92AN: 250852Hom.: 0 AF XY: 0.000376 AC XY: 51AN XY: 135654
GnomAD3 exomes
AF:
AC:
92
AN:
250852
Hom.:
AF XY:
AC XY:
51
AN XY:
135654
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000220 AC: 322AN: 1461778Hom.: 0 Cov.: 30 AF XY: 0.000219 AC XY: 159AN XY: 727188
GnomAD4 exome
AF:
AC:
322
AN:
1461778
Hom.:
Cov.:
30
AF XY:
AC XY:
159
AN XY:
727188
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000191 AC: 29AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74340
GnomAD4 genome
AF:
AC:
29
AN:
152174
Hom.:
Cov.:
32
AF XY:
AC XY:
19
AN XY:
74340
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
38
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2022 | The c.673G>C (p.V225L) alteration is located in exon 7 (coding exon 7) of the MRPL9 gene. This alteration results from a G to C substitution at nucleotide position 673, causing the valine (V) at amino acid position 225 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Benign
T;D
Polyphen
D;.
Vest4
MutPred
Loss of catalytic residue at V225 (P = 0.2112);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at